A Trial to Evaluate the Safety and Efficacy of NCR102 in Subjects With aGVHD
Clinical trial NCT06941350 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06941350
- Sponsor
- Nuwacell Biotechnologies Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-28
- Primary completion
- 2026-10-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.